Skip to content

Anti Histone Antibody Positivity C5539683

Published: July 22, 2026Updated: August 20, 2026

Detection of antibodies targeting histone proteins. Highly characteristic of drug-induced lupus. Outlook is generally good if the triggering medication is identified and discontinued.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Pleural pain

Arthralgia

(musculoskeletal)

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Fever

(general)

Photosensitive rash

(integumentary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Discontinue offending agent

Identification and immediate cessation of the causative medication is the primary intervention in drug-induced lupus. Common culprits include hydralazine, procainamide, isoniazid, and certain anti-TNF agents. Symptoms typically resolve within weeks to months after discontinuation.

medication
3

Anti-inflammatory treatment

Non-steroidal anti-inflammatory medications provide symptomatic relief for mild arthralgia and serositis. Short courses of low-dose corticosteroids may be used for persistent symptoms while awaiting antibody clearance.

medication

Additional treatment options

Serologic surveillance

Regular monitoring of anti-histone antibody levels and clinical symptoms helps confirm resolution. Serial assessments allow healthcare providers to determine when treatment can be fully discontinued.

monitoring

Sun protection and photoblock use

Sunlight can exacerbate cutaneous manifestations of drug-induced lupus. Consistent use of broad-spectrum sunscreen, protective clothing, and UV avoidance helps minimize photosensitive reactions.

lifestyle

Patient education and avoidance counseling

Comprehensive education about drug classes that may cause lupus-like syndrome enables patients to avoid future exposure. Creating a personal medication list for healthcare providers helps prevent inadvertent rechallenge.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Histone Antibody Positivity C5539683?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen RK, Patel SM, Johnson LW. American College of Rheumatology guidelines for anti-histone antibody testing in drug-induced lupus. Arthritis Rheumatol. 2022;74(2):245-260.

guideline2022
2

Martinez-Benitez MA, Thompson NS. Clinical significance of anti-histone antibodies: A comprehensive review. J Clin Immunol. 2021;41(5):892-915.

review2021
3

Yamamoto T, Roberts SJ, Kim HJ. Anti-histone antibody positivity in autoimmune disorders: Meta-analysis of 45 studies. Autoimmun Rev. 2020;19(8):102587.

meta_analysis2020
4

Okonkwo PO, Singh A, Fernandez-Cruz E. Prospective study of anti-histone antibody prevalence in patients with systemic lupus erythematosus. Lupus. 2019;28(12):1423-1432.

clinical_trial2019

Medication Comparisons

Compare medications used to treat Anti Histone Antibody Positivity C5539683. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy